Application of mass spectrometry technologies for the discovery of low-molecular weight modulators of enzymes and protein-protein interactions

被引:23
作者
Zehender, Hartmut [1 ]
Mayr, Lorenz M. [1 ]
机构
[1] NIBR, CH-4002 Basel, Switzerland
关键词
D O I
10.1016/j.cbpa.2007.08.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In recent years, mass spectrometry has gained widespread use as an assay and screening technology in drug discovery because it enables sensitive, label-free detection of low-molecular weight modulators of biomolecules as well as sensitive and accurate detection of high-molecular weight modifications of biomolecules. Electrospray and matrix-assisted laser desorption ionization are the most widely used ionization techniques to identify chemical compounds interfering with enzymatic function, receptor-ligand binding or molecules modulating a protein-protein interaction of interest. Mass spectrometry based techniques are no longer restricted to screening in biochemical assay systems but have now become also applicable to imaging of biomolecules and chemical compounds in cell-based assay systems and even in highly complex tissue sections.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 30 条
[21]   SAR by MS: Discovery of a new class of RNA-binding small molecules for the hepatitis C virus: Internal ribosome entry site IIA subdomain [J].
Seth, PP ;
Miyaji, A ;
Jefferson, EA ;
Sannes-Lowery, KA ;
Osgood, SA ;
Propp, SS ;
Ranken, R ;
Massire, C ;
Sampath, R ;
Ecker, DJ ;
Swayze, EE ;
Griffey, RH .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7099-7102
[22]   Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery [J].
Slon-Usakiewicz, JJ ;
Ng, W ;
Dai, JR ;
Pasternak, A ;
Redden, PR .
DRUG DISCOVERY TODAY, 2005, 10 (06) :409-416
[23]   High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry [J].
Wan, H ;
Rehngren, M .
JOURNAL OF CHROMATOGRAPHY A, 2006, 1102 (1-2) :125-134
[24]   Desorption-ionization mass spectrometry on porous silicon [J].
Wei, J ;
Buriak, JM ;
Siuzdak, G .
NATURE, 1999, 399 (6733) :243-246
[25]   Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry [J].
Whitehurst, CE ;
Nazef, N ;
Annis, DA ;
Hou, YM ;
Murphy, DM ;
Spacciapoli, P ;
Yao, ZP ;
Ziebell, MR ;
Cheng, CC ;
Shipps, GW ;
Flesch, JS ;
Lau, D ;
Nash, HM .
JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (02) :194-207
[26]   High-throughput mass-spectroscopy monitoring for multisubstrate enzymes: Determining the kinetic parameters and catalytic activities of glycosyltransferases [J].
Yang, M ;
Brazier, M ;
Edwards, R ;
Davis, BG .
CHEMBIOCHEM, 2005, 6 (02) :346-357
[27]   SpeedScreen: the "missing link" between genomics and lead discovery [J].
Zehender, H ;
Le Goff, F ;
Lehmann, N ;
Filipuzzi, I ;
Mayr, LM .
JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (06) :498-505
[28]   Application of high-throughput affinity-selection mass spectrometry for screening of chemical compound libraries in lead discovery [J].
Zehender, Hartmut ;
Mayr, Lorenz M. .
EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (02) :285-294
[29]   FT-ICR mass spectrometry in the drug discovery process [J].
Zhang, J ;
McCombie, G ;
Guenat, C ;
Knochenmuss, R .
DRUG DISCOVERY TODAY, 2005, 10 (09) :635-642
[30]   Frontal affinity chromatography combined on-line with mass spectrometry: A tool for the binding study of different epidermal growth factor receptor inhibitors [J].
Zhu, LL ;
Chen, LR ;
Luo, HP ;
Xu, XJ .
ANALYTICAL CHEMISTRY, 2003, 75 (23) :6388-6393